ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för AZ505. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

18 träffar

Bibliografisk träff 2023-07-07

Pharmacological inhibition of SMYD2 protects against cisplatin-induced renal fibrosis and inflammation.

Chen M, Zuo S, Chen S, Li X, Zhang T, Yang D, Zou X, Yang Y, Long H, Peng R, Yuan H, Guo B, Liu L.

J Pharmacol Sci · journal article · DOI 10.1016/j.jphs.2023.07.003

Bibliografisk träff 2023-06-14

SMYD2 inhibition-mediated hypomethylation of Ku70 contributes to impaired nonhomologous end joining repair and antitumor immunity.

Tang M, Chen G, Tu B, Hu Z, Huang Y, DuFort CC, Wan X, Mao Z, Liu Y, Liu Y, Zhu WG, Lu W.

Sci Adv · research-article; journal article · DOI 10.1126/sciadv.ade6624

Bibliografisk träff 2023-04-10

Targeting SMYD2 inhibits prostate cancer cell growth by regulating c-Myc signaling.

Li J, Wan F, Zhang J, Zheng S, Yang Y, Hong Z, Dai B.

Mol Carcinog · research support, non-u.s. gov't; journal article · DOI 10.1002/mc.23536

Bibliografisk träff 2022-08-15

Pharmacological inhibition of SMYD2 protects against cisplatin-induced acute kidney injury in mice.

Cui B, Hou X, Liu M, Li Q, Yu C, Zhang S, Wang Y, Wang J, Zhuang S, Liu F.

Front Pharmacol · research-article; journal article · DOI 10.3389/fphar.2022.829630

Bibliografisk träff 2022-08-08

STUB1-SMYD2 Axis Regulates Drug Resistance in Glioma cells.

Pan K, Hu B, Wang L, Yuan J, Xu W.

J Mol Neurosci · journal article · DOI 10.1007/s12031-022-02051-5

Bibliografisk träff 2022-06-27

Cross talk between lysine methyltransferase Smyd2 and TGF-β-Smad3 signaling promotes renal fibrosis in autosomal dominant polycystic kidney disease.

Li LX, Zhang L, Agborbesong E, Zhang X, Zhou JX, Li X.

Am J Physiol Renal Physiol · research-article; journal article; research support, n.i.h., extramural · DOI 10.1152/ajprenal.00452.2021

Bibliografisk träff 2022-04-08

SMYD2 Inhibition Downregulates TMPRSS2 and Decreases SARS-CoV-2 Infection in Human Intestinal and Airway Epithelial Cells.

Yu YQ, Herrmann A, Thonn V, Cordsmeier A, Neurath MF, Ensser A, Becker C.

Cells · research support, non-u.s. gov't; research-article; journal article · DOI 10.3390/cells11081262

Bibliografisk träff 2021-11-30

Effects of the Lysine Methyltransferase Inhibitor AZ505 on Bone Metabolism.

Song MK, Jung S, Hong S, Kwon JO, Kim MK, Kim HH.

J Bone Metab · research-article; journal article · DOI 10.11005/jbm.2021.28.4.297

Bibliografisk träff 2021-09-12

Novel insights into SMYD2 and SMYD3 inhibitors: from potential anti-tumoural therapy to a variety of new applications.

Rubio-Tomás T.

Mol Biol Rep · review; journal article · DOI 10.1007/s11033-021-06701-6

Bibliografisk träff 2021-07-01

Critical roles of SMYD2 lysine methyltransferase in mediating renal fibroblast activation and kidney fibrosis.

Liu L, Liu F, Guan Y, Zou J, Zhang C, Xiong C, Zhao TC, Bayliss G, Li X, Zhuang S.

FASEB J · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1096/fj.202000554rrr

Bibliografisk träff 2021-05-02

SMYD2 promotes tumorigenesis and metastasis of lung adenocarcinoma through RPS7.

Wu L, Kou F, Ji Z, Li B, Zhang B, Guo Y, Yang L.

Cell Death Dis · research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/s41419-021-03720-w

Bibliografisk träff 2020-04-10

<i>Leishmania donovani</i> Subverts Host Immune Response by Epigenetic Reprogramming of Macrophage M(Lipopolysaccharides + IFN-γ)/M(IL-10) Polarization.

Parmar N, Chandrakar P, Kar S.

J Immunol · research support, non-u.s. gov't; journal article · DOI 10.4049/jimmunol.1900251

Bibliografisk träff 2019-10-22

Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma.

Yan L, Ding B, Liu H, Zhang Y, Zeng J, Hu J, Yao W, Yu G, An R, Chen Z, Ye Z, Xing J, Xiao K, Wu L, Xu H.

Theranostics · research support, non-u.s. gov't; research-article; journal article · DOI 10.7150/thno.37628

Bibliografisk träff 2018-02-27

Lysine methyltransferase SMYD2 promotes triple negative breast cancer progression.

Li LX, Zhou JX, Calvet JP, Godwin AK, Jensen RA, Li X.

Cell Death Dis · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1038/s41419-018-0347-x

Bibliografisk träff 2017-06-12

Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease.

Li LX, Fan LX, Zhou JX, Grantham JJ, Calvet JP, Sage J, Li X.

J Clin Invest · research-article; journal article · DOI 10.1172/jci90921

Bibliografisk träff 2017-06-06

The lysine methyltransferase SMYD2 methylates the kinase domain of type II receptor BMPR2 and stimulates bone morphogenetic protein signaling.

Gao S, Wang Z, Wang W, Hu X, Chen P, Li J, Feng X, Wong J, Du JX.

J Biol Chem · research support, non-u.s. gov't; research-article; journal article · DOI 10.1074/jbc.m117.776278

Bibliografisk träff 2014-12-01

Effectiveness of a home-based pulmonary rehabilitation programme in pulmonary function and health related quality of life for patients with pulmonary tuberculosis: a pilot study.

de Grass D, Manie S, Amosun SL.

Afr Health Sci · research support, non-u.s. gov't; research-article; randomized controlled trial; journal article · DOI 10.4314/ahs.v14i4.14

Bibliografisk träff 2011-07-21

Structural basis of substrate methylation and inhibition of SMYD2.

Ferguson AD, Larsen NA, Howard T, Pollard H, Green I, Grande C, Cheung T, Garcia-Arenas R, Cowen S, Wu J, Godin R, Chen H, Keen N.

Structure · journal article · DOI 10.1016/j.str.2011.06.011